COVID-19

New survey findings show the antimalarial drug's promotion for potential SARS-CoV-2 benefit early into the pandemic led to needing patients losing access.

Data suggest patients administered tofacitinib for their arthritis do not face worsened risk, severity of flu infection.

The first 3 months of the pandemic were marked by a significant rate of patients changing or discontinuing medication without clinician guidance.

New data from ACR 2020 assure concerns that patients with arthritis who test positive for COVID-19 may be at worse risk of ICU admission or even death.

Up to 91% of the gastroenterologist respondents plan to integrate telehealth into their practice following the COVID-19 pandemic.

In data presented at ACG 2020, researchers show a combination of sulindac and eflornithine could be effective for FAP patients.

Compared with prophylaxis anticoagulation, full dose anticoagulation provided a greater survival benefit to those in a predominantly black population.

New data presented at IDWeek showed more than half observed households with a COVID-19 case reported a secondary infection, oftentimes within 3 days.

Dr. Schaffner explains how social distancing and masks could also reduce the spread of influenza.

New data show patients hospitalized with COVID-19 far more frequently suffer from cardiometabolic disease, yet face worse outcomes with COPD.

The COVID-19 pandemic has placed burdens on access to in-person health services; therefore, safe and practical allergy management / prevention processes are necessary.

Patients diagnosed with neurologic disorders post-admission were less likely to be discharged home than those with events prior to, or at the time of admission.

The quadrivalent, virus-like particle influenza vaccine has potential to offer substantial protection in adults.

The rate of maternal clinical insomnia has increased from 11% prior to the pandemic to 23% during the COVID-19 pandemic.

Dr. Kliger discusses how nephrologists can safely treat patients this winter.

Two-thirds of all excess deaths this year have been directly driven by the pandemic, according to findings.

Paul Christo, MD, discusses opioid addiction during the pandemic, the role of the clinician, and offers a hopeful outlook for the future.

Experts expect an increase in mental health issues caused by the pandemic in the future.

An expert discusses trends in pediatric mental health and receipt of treatment.

Dr. Fauci gives perspective on the future presence of the virus, improving US pandemic preparedness, and the theological divisions which have plagued national response.

Nephrologists have used telemedicine tools to help treat patients during the pandemic.

An expert discusses the effect the pandemic has had on opioid use and related deaths.

The risk of VTE is increased in both hospitalized and non-hospitalized COVID-19 patients.

What the potential of monoclonal antibodies may be, and what's currently understood about serologic antibodies.

There could be a lasting impact caused by some of the changes due to the pandemic.

A high proportion of end-stage kidney disease patients have suffered severe COVID-19 outcomes.

An expert discusses how allergies can make it easier for viruses to enter the body as well as the association between asthma and COVID-19 severity.

Fauci shares his thoughts on leading COVID-19 vaccines, SARS-CoV-2 transmission, antibody research, and where the US went wrong in pandemic response.

For many patients suffering from depression or anxiety, the added stress of the pandemic has led to a medication change.

Educating patients of the immune system can be helpful in addressing any concerns over getting vaccinated for the flu.